Skip to main content
. Author manuscript; available in PMC: 2019 Jun 28.
Published in final edited form as: J Med Invest. 2018;65(12):64–68. doi: 10.2152/jmi.65.64

Figure 2.

Figure 2.

Plasma levels of VEGF and sFlt-1 in HAPE patients(n=10) before and after treatments. A. Plasma levels of VEGF were significantly higher in the before treatment group and reduced after treatments. B. Similarly, plasma levels of sFlt-1 level were increased at the onset of HAPE and decreased after treatments. **p<0.01